Ex Parte Chatty et al - Page 6

                Appeal 2007-1360                                                                              
                Application 10/605,699                                                                        
                dependent claims 2-4, 7-10, 15-18, 20, 21, 23-25, 28, 30, and 31 not                          
                separately argued by Appellants, is sustained.                                                
                      We also sustain the Examiner’s 35 U.S.C. § 102(b) rejection, based on                   
                Kim, of dependent claims 19 and 29 which set forth the use of the claimed                     
                latch-up prevention CMOS semiconductor structure to prevent latch-up from                     
                a cable discharge.  We find no error in the Examiner’s position (Answer 5,                    
                8) that such claim language is a mere recitation of intended  use and does not                
                serve to distinguish over the CMOS semiconductor structure disclosed by                       
                Kim.  Further, the record before us is totally devoid of any evidence to                      
                support Appellants’ contention (Br. 8) that Kim’s disclosed structure would                   
                not be applicable to what Appellants have termed “non-standard” latch-up                      
                tests “arising from a cable discharge event” due to Kim’s requirement for a                   
                large N-well guard ring for latch-up prevention.                                              
                      Turning to a consideration of the Examiner’s 35 U.S.C. § 102(b)                         
                rejection of dependent claims 5, 6, 26, and 27, based on Kim, we sustain this                 
                rejection as well.  Appellants argue (Reply Br. 5) that Kim does not disclose                 
                the spacing of contact regions 22, 23, and 41 which “varies with the                          
                proximity” of the contact regions to the injection site.  We do not find this                 
                persuasive since the language quoted by Appellants appears only in                            
                dependent claims 2 and 23.  On the other hand, dependent claims 5, 6 and                      
                26, 27 are ultimately dependent, respectively, on claims 4 and 25, which                      
                depend, respectively, from independent claims 1 and 22 and do not include                     
                claims 2 and 23 in their dependency chain.                                                    
                      We also sustain the Examiner’s 35 U.S.C. § 102(b) rejection of claims                   
                1, 7, and 11-14 based on Magee.  Appellants’ arguments in response (Br. 9-                    
                10; Reply Br. 5-7) mirror those made with respect to Kim, and we find such                    

                                                      6                                                       

Page:  Previous  1  2  3  4  5  6  7  Next

Last modified: September 9, 2013